Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
13 January 2015 |
Main ID: |
ISRCTN82694463 |
Date of registration:
|
13/03/2001 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
A phase III study of primary chemotherapy in T2 (G3), T3 and T4a; N0 or NX; M0 transitional cell carcinoma (TCC) of the bladder
|
Scientific title:
|
|
Date of first enrolment:
|
01/12/1989 |
Target sample size:
|
975 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN82694463 |
Study type:
|
Interventional |
Study design:
|
Randomised controlled trial (Treatment)
|
Phase:
|
|
|
Countries of recruitment
|
United Kingdom
| | | | | | | |
Contacts
|
Name:
|
Barbara
Uscinska |
Address:
|
MRC Clinical Trials Unit
222 Euston Road
NW1 2DA
London
United Kingdom |
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Histologically proven TCC of the bladder with biopsy-proven muscle invasion 2. Tumours considered curable (less than or equal to 7 cm) 3. GFK =50 ml/min (Cockcroft) 4. White blood count (WBC) >3.5 x 10^9/L and platelet count >100 x 10^9/L
Exclusion criteria: Not provided at time of registration
Age minimum:
Age maximum:
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Bladder cancer Cancer Transitional cell carcinoma (TCC) of the bladder
|
Intervention(s)
|
Primary chemotherapy in T2 (G3), T3 and T4a; N0 or NX; M0 TCC of the bladder
|
Primary Outcome(s)
|
Survival
|
Secondary Outcome(s)
|
Not provided at time of registration
|
Source(s) of Monetary Support
|
Medical Research Council (MRC) (UK)
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|